CellaVision Diff IQ allows laboratories to ensure that their staff is trained to report results consistent with lab policies and to help to guarantee the consistency and quality of the differential result. The combination of high quality digital images, sophisticated data analysis tools and a user-friendly interface standardizes the differential between medical technologists, shifts and sites.
"The hematology market in the U.S. has shown great interest in our developments, which we believe is due to the perfect fit of our hematology products with the laboratories' objectives and long term needs. With the launch of CellaVision Diff IQ we have a strong product portfolio and we can offer a tool for standardization of differential results to the market," says Peter Wilson, Product Manager at CellaVision.
CellaVision Diff IQ will be demonstrated by Sysmex America, Inc. and CellaVision on July 24-28 at the joint meeting of the XIX International Congress of Clinical Chemistry and the 2005 Annual Meeting of the American Association for Clinical Chemistry (AACC) in Orlando, Florida, USA.
Product information
CellaVision Diff IQ is a software package for education and proficiency testing of manual blood cell differentials in laboratories. The product allows labs to reduce the resources needed to test and train their staff, and it helps standardize the lab's white blood cell differential results across technologists, shifts and sites. Testing is established by the laboratories' 'examiner', who chooses and classifies the cells to be included in the test case, performed by the participant.
CellaVision Diff IQ software includes CellaVision cell databases of slides. The CellaVision Diff IQ databases contain images of slides stained with either a May Grünwald Giemsa or a Wright staining protocol. They contain 9-10 slides, each having approximately 100 white blood cell images and a large RBC overview image for RBC characterization. Users of CellaVision(TM) DM96 or DM8 systems have the additional ability to create cell databases from slides processed on their own systems.
About CellaVision
CellaVision AB is an emerging high-tech company with a core competence in development of software for automatic image analysis of cells and cell changes and for applications in health and medical care. The company offers cutting-edge expertise in sophisticated image processing, image analysis and automated microscopy. It develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials.
CellaVision AB is an emerging high-tech company with a core competence in development of software for automatic image analysis of cells and cell changes and for applications in health and medical care. The company offers cutting-edge expertise in sophisticated image processing, image analysis and automated microscopy. It develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials.
The company headquarters are in Lund, Sweden. The company also has a U.S. subsidiary in Jupiter, Fl, USA. For more information about CellaVision, visit http://www.cellavision.com/.
About Sysmex
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systematization and solutions, including clinical diagnostics, automation and information systems that elevate clinical laboratory medicine to first-line patient care. Sysmex America, Inc. focuses on extending the boundaries of in vitro diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. Additional information about Sysmex America, Inc. can be found at www.sysmex.com/usa.
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systematization and solutions, including clinical diagnostics, automation and information systems that elevate clinical laboratory medicine to first-line patient care. Sysmex America, Inc. focuses on extending the boundaries of in vitro diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. Additional information about Sysmex America, Inc. can be found at www.sysmex.com/usa.
For more information, please contact:
Peter Wilson, Product Manager, CellaVision AB
Phone: +46 46 286 4400. E-mail: peter.wilson@cellavision.com
Peter Åkerlund, CFO, CellaVision AB
Phone: +46 46 286 4400. E-mail: peter.akerlund@cellavision.com